Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GNMX vs. IYH: which is better?

Bottom line

GNMX vs IYH: the short answer

GNMX (Corgi Genomics & Precision Medicine ETF) and IYH (iShares U.S. Healthcare ETF) are both etfs.

Updated Nov 19, 2026

GNMX vs IYH side by side

GNMXIYH
TypeETFETF
Fund familyCorgi Genomics & Precision MedicineiShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.37%
Annual cost per $10k—$37
10-yr cost on $10k (prospectus)—$468
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+13.1%
5-yr return (annualized)—+7.0%
10-yr return (annualized)—+9.4%
Best quarter—+15.3%
Worst quarter—−12.7%
Net assets (fund)—$3.6B
Number of holdings—103
Portfolio turnover—3%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

GNMX and IYH share none of their top holdings.

GNMX top 10

    IYH top 10

    1. Eli Lilly And Company — 15.11%
    2. Johnson & Johnson — 10.17%
    3. Abbvie Inc. — 7.32%
    4. Unitedhealth Group Incorporated — 6.16%
    5. Merck & Co., Inc. — 5.31%
    6. Thermo Fisher Scientific Incorporated — 3.52%
    7. Amgen Inc. — 3.42%
    8. Abbott Laboratories — 3.02%
    9. Gilead Sciences, Inc. — 2.66%
    10. Pfizer Inc. — 2.35%

    FAQ

    What is the difference between GNMX and IYH?
    GNMX (Corgi Genomics & Precision Medicine ETF) and IYH (iShares U.S. Healthcare ETF) are both etfs.
    Should I own both GNMX and IYH?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.